▲ 61 r/HerpesCureResearch
u/RoundProfessional148 — 6 days ago
Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program
Based on the article, it can be inferred that Gilead may already have plans for Phase 3
1.This decision follows Assembly Bio’s receipt and review of Gilead’s complete development plan and budget for the program.
2.Under the development plan, GS-1179 is expected to advance into a Phase 2 clinical trial in participants with recurrent genital herpes by the end of 2026, with potential evaluation as part of a combination strategy with HIV pre-exposure prophylaxis (PrEP)
u/FitIndependence9648 — 1 month ago
▲ 71 r/HerpesCureResearch
Gilead Selects GS-1179, Phase 2 Trial in Recurrent Genital Herpes Planned by Year-End 2026
investor.assemblybio.comu/RoundProfessional148 — 2 months ago
▲ 115 r/HerpesCureResearch
Innovative Molecules Announces First Patient Dosed in Phase 2a Trial of Adibelivir (IM-250), Advancing Company into Late-Stage Clinical Development
reddit.comu/RoundProfessional148 — 4 months ago
https://investor.assemblybio.com/events-presentations
Looking at the PPT, functional cure might actually be possible.
Let's all stay strong and move forward.
u/RoundProfessional148 — 6 months ago